Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.01 (0.39%)
Bid:
2.60
Ask:
2.80
Spread: 0.20 (7.692%)
Market Cap: £4.74m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Board Changes

29 Apr 2013 07:00

RNS Number : 4271D
Nanoco Group PLC
29 April 2013
Β 

ο»Ώ

Β For immediate release

29 April 2013

Β 

Β 

NANOCO GROUP PLC

("Nanoco" or the "Company")

Β 

Board Changes

Β 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that its Non-Executive Chairman, Peter Rowley, has stepped down from the role of Chairman after serving for seven years to become a Non-Executive Director of the Company. Anthony Clinch, who became a Non-Executive Director of Nanoco in March 2010, has been appointed Non-Executive Chairman. These changes are effective from 26 April 2013.

Β 

Michael Edelman, Nanoco's CEO, said: "I would like to thank Peter for his enormous contribution to the development of Nanoco during his seven years as Chairman. I am delighted that we will continue to benefit from his counsel as a Non-Executive Director."

Β 

Β 

Β 

Β 

For further information:

Β 

Nanoco

+ 44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Canaccord Genuity - Nomad and Joint Broker

+44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Liberum Capital - Joint Broker

+ 44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

Β 

Β 

Notes for editors:

Β 

AboutΒ Nanoco GroupΒ plc

Β 

Nanoco is a world leader in the development and production of cadmium-free quantum dots for use in multiple applications including LCD displays, lighting and solar cells. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

Β 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and business development offices in the USA, Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAEAFLPAFKDEAF
Date   Source Headline
17th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20247:00 amRNSConclusions of Strategic Review
1st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 202410:51 amRNSHolding(s) in Company
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20241:08 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20241:34 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Aug 20247:00 amRNSCommercial Update
29th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:21 amRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20249:16 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20247:00 amRNSBoard and Management Change
25th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jul 20242:14 pmRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.